Stock Information
Arrowhead Pharmaceuticals Inc (ARWR)
Ticker Symbol: ARWR
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $8,592.67 mil
Piotroski score: 5
PE Ratio: 39.2338
EPS (TTM): 1.5409
Revenue (TTM): $7.75 M
Dividend Yield: N/A%
ROE: 36.12%
Latest News
-
Sarepta Plans FDA Filings Seeking Full Approval for Two DMD Therapies
Fri, Mar 20, 2026 2:47 PM
-
A Look At Arrowhead Pharmaceuticals (ARWR) Valuation As Recent Momentum Cools After A Strong Run
Fri, Mar 20, 2026 10:03 AM
-
Arrowhead Pharmaceuticals Inc. (ARWR): Billionaire Ken Fisher Bets Big on Pharma
Tue, Mar 17, 2026 8:14 PM
-
SRPT Stock Up as Enrollment Begins in DMD Gene Therapy Safety Study
Tue, Mar 17, 2026 2:35 PM
-
10 Health Care Stocks Whale Activity In Today's Session
Tue, Mar 17, 2026 1:35 PM
Key Financials
Financial data not available
